Post-marketing Study Assessing the Long-Term Safety of Abatacept
Status:
Completed
Trial end date:
2017-02-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the risk of infections and malignancies among
Rheumatoid Arthritis (RA) patients treated with Abatacept compared to other RA treatments.